ORAGENICS, INC. Earnings Per Share (Basic)
ORAGENICS, INC. (OGEN) reported Earnings Per Share (Basic) of -$0.57 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- ORAGENICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.57.
- ORAGENICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.51.
- ORAGENICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.96.
- ORAGENICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$3.10.
- ORAGENICS, INC. earnings per share, basic for fiscal 2025 was -$4.56.
- ORAGENICS, INC. earnings per share, basic for fiscal 2024 was -$47.88.
- ORAGENICS, INC. earnings per share, basic for fiscal 2023 was -$9.18.
- ORAGENICS, INC. earnings per share, basic for fiscal 2022 was -$7.11.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 4 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.57 10-Q · filed 2026-08-13 | -$1.08 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | -$0.51 10-Q · filed 2026-05-08 | ||||||||
| 2025-12-31 | -$4.56 10-K · filed 2026-03-16 | ||||||||
| 2025-09-30 | -$1.96 10-Q · filed 2025-11-07 | -$5.16 10-Q · filed 2025-11-07 | |||||||
| 2025-06-30 | -$3.10 10-Q · filed 2026-08-13 | -$6.62 10-Q · filed 2026-08-13 | |||||||
| 2025-03-31 | -$3.65 10-Q · filed 2026-05-08 | -$0.12 10-Q · filed 2025-05-09 | |||||||
| 2024-12-31 | -$47.88 10-K · filed 2026-03-16 | -$1.60 10-K · filed 2025-03-14 | |||||||
| 2024-09-30 | -$11.32 10-Q · filed 2025-11-07 | -$0.38 10-Q · filed 2024-11-13 | -$101.37 10-Q · filed 2025-11-07 | -$1.49 10-Q · filed 2024-11-13 | |||||
| 2024-06-30 | -$15.27 10-Q · filed 2025-08-08 | -$0.51 10-Q · filed 2024-08-09 | -$35.56 10-Q · filed 2025-08-08 | -$1.19 10-Q · filed 2024-08-09 | |||||
| 2024-03-31 | -$0.70 10-Q · filed 2025-05-09 | ||||||||
| 2023-12-31 | -$9.18 10-K · filed 2025-03-14 | ||||||||
| 2023-09-30 | -$0.85 10-Q · filed 2024-11-13 | -$3.70 10-Q · filed 2024-11-13 | |||||||
| 2023-06-30 | -$1.51 10-Q · filed 2024-08-09 | -$3.04 10-Q · filed 2024-08-09 | -$2.91 10-Q · filed 2023-08-11 | ||||||
| 2023-03-31 | -$1.41 10-Q · filed 2024-05-15 | ||||||||
| 2022-12-31 | -$7.11 10-K · filed 2024-03-29 | ||||||||
| 2022-09-30 | -$1.99 10-Q · filed 2023-11-09 | -$0.03 10-Q · filed 2022-11-14 | -$6.21 10-Q · filed 2023-11-09 | -$0.12 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | -$1.85 10-Q · filed 2023-08-11 | -$0.03 10-Q · filed 2022-08-09 | -$0.03 10-Q/A · filed 2023-04-14 | -$4.22 10-Q · filed 2023-08-11 | -$0.09 10-Q · filed 2022-08-09 | ||||
| 2022-03-31 | -$2.29 10-Q · filed 2023-05-12 | -$0.05 10-Q · filed 2022-05-13 | |||||||
| 2021-12-31 | -$8.09 10-K · filed 2023-04-17 | -$0.14 10-K/A · filed 2022-07-29 | |||||||
| 2021-09-30 | -$0.04 10-Q/A · filed 2023-04-14 | -$0.12 10-Q/A · filed 2023-04-14 | |||||||
| 2021-06-30 | -$0.03 10-Q/A · filed 2023-04-14 | -$0.08 10-Q/A · filed 2023-04-14 | |||||||
| 2021-03-31 | -$0.05 10-Q/A · filed 2023-04-14 | ||||||||
| 2020-12-31 | -$0.47 10-K/A · filed 2022-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |